GT Biopharma, Inc.
GTBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$8 | -$21 | -$58 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2 | $8 | $34 |
| Change in WC | $1 | $2 | -$2 | $8 |
| Other Non-Cash | -$1 | -$5 | $0 | $1 |
| Operating Cash Flow | -$13 | -$9 | -$15 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $13 | $0 | $12 | -$23 |
| Inv. Sales/Matur. | $0 | $0 | $12 | $0 |
| Other Inv. Act. | $0 | -$2 | -$12 | $0 |
| Investing Cash Flow | $13 | -$2 | $12 | -$23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1 |
| Stock Issued | $3 | $6 | $0 | $25 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $16 |
| Financing Cash Flow | $3 | $6 | -$0 | $42 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3 | -$5 | -$3 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $6 | $9 | $5 |
| End Cash | $4 | $1 | $6 | $9 |
| Free Cash Flow | -$13 | -$9 | -$15 | -$16 |